Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP347224.RAXFGm-fCfFljYSu2PuJPps7RGQ6Lfvsqv6rhzXIX0avM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP347224.RAXFGm-fCfFljYSu2PuJPps7RGQ6Lfvsqv6rhzXIX0avM130_assertion type Assertion NP347224.RAXFGm-fCfFljYSu2PuJPps7RGQ6Lfvsqv6rhzXIX0avM130_head.
- NP347224.RAXFGm-fCfFljYSu2PuJPps7RGQ6Lfvsqv6rhzXIX0avM130_assertion description "[The methylation frequencies of the 10 genes examined in NSCLC were 26% for DAPK, 34% for FHIT, 26% for H-cadherin, 14% for MGMT, 8% for p14, 27% for p16, 38% for RAR-beta, 42% for RASSF1A, 25% for RUNX3, and 12% for TIMP-3.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP347224.RAXFGm-fCfFljYSu2PuJPps7RGQ6Lfvsqv6rhzXIX0avM130_provenance.
- NP347224.RAXFGm-fCfFljYSu2PuJPps7RGQ6Lfvsqv6rhzXIX0avM130_assertion evidence source_evidence_literature NP347224.RAXFGm-fCfFljYSu2PuJPps7RGQ6Lfvsqv6rhzXIX0avM130_provenance.
- NP347224.RAXFGm-fCfFljYSu2PuJPps7RGQ6Lfvsqv6rhzXIX0avM130_assertion SIO_000772 17606310 NP347224.RAXFGm-fCfFljYSu2PuJPps7RGQ6Lfvsqv6rhzXIX0avM130_provenance.
- NP347224.RAXFGm-fCfFljYSu2PuJPps7RGQ6Lfvsqv6rhzXIX0avM130_assertion wasDerivedFrom befree-20150227 NP347224.RAXFGm-fCfFljYSu2PuJPps7RGQ6Lfvsqv6rhzXIX0avM130_provenance.
- NP347224.RAXFGm-fCfFljYSu2PuJPps7RGQ6Lfvsqv6rhzXIX0avM130_assertion wasGeneratedBy ECO_0000203 NP347224.RAXFGm-fCfFljYSu2PuJPps7RGQ6Lfvsqv6rhzXIX0avM130_provenance.